ArticleRadiation oncology (London, England)2023

Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer.

Lea Hoppen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.